Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma

Single-nucleotide polymorphism in the promoter region of the osteopontin gene at nucleotide −443 as a marker predicting the efficacy of pegylated interferon/ribavirin-therapy in Egyptians patients with chronic hepatitis C

(2012) Olfat Gamil Shaker et al.   HUMAN IMMUNOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Identification of osteopontin as a novel marker for early hepatocellular carcinoma

(2011) Sufen Shang et al.   HEPATOLOGY

High-resolution characterization of a hepatocellular carcinoma genome

(2011) Yasushi Totoki et al.   NATURE GENETICS

The importance of phase information for human genomics

(2011) Ryan Tewhey et al.   NATURE REVIEWS GENETICS

Exploring the Genomes of Cancer Cells: Progress and Promise

(2011) M. R. Stratton   SCIENCE

Beyond the Transcripts: What Controls Protein Variation?

(2011) Laura Straub   PLOS BIOLOGY

The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis

(2010) Chia-Chu Liu et al.   CLINICA CHIMICA ACTA

Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma

(2010) Yu-Hua Xue et al.   HEPATOLOGY

Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression

(2010) Masashi Sakaki et al.   HEPATOLOGY RESEARCH

A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci

(2010) Jin-Xin Bei et al.   NATURE GENETICS

The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis

(2010) Yu-Wei Chiu et al.   ORAL ONCOLOGY

Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin

(2008) Sandra S. McAllister et al.   CELL

Down-Regulation of Osteopontin Suppresses Growth and Metastasis of Hepatocellular Carcinoma Via Induction of Apoptosis

(2008) Jian Zhao et al.   GASTROENTEROLOGY

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma

(2008) Bing-Sheng Sun et al.   HEPATOLOGY

The functional −443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor

(2008) Julia Schultz et al.   MOLECULAR CARCINOGENESIS